Skip to main content

Table 2 Treatment characteristics

From: Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Patient Age Site treated Prescribed dose (Gy) Fractions (n) PTV volume (cc) PTV maximum dose (Gy) PTV minimum dose (Gy) PTV mean dose (Gy)
1 56 Liver 50 5 30.5 59.8 35.8 55.3
  57 Liver 45 5 16.0 49.4 36.5 46.4
  57 Lymph node 45 5 30.4 49.1 34.9 45.7
2 59 Liver 50 5 412.4 56.8 35.0 53.4
3 69 Liver 60 3 67.0 68.9 52.9 65.4
4 82 Liver 60 5 150.2 76.2 48.7 68.2
5 56 Liver 45 5 91.2 52.4 31.9 47.8
6 51 Liver 60 5 224.3 65.1 25.0 60.6
7 70 Liver 60 3 26.6 64.7 55.5 61.9
8 64 Liver 60 5 121.5 68.5 26.5 61.5
9 67 Adrenal 50 5 61.0 54.5 45.4 51.6
10 87 Liver 60 5 133.5 75.7 12.1 62.2